ClinicalTrials.Veeva

Menu

Predictors of Recurrence for High Risk Endometrial Cancer Patients

F

Far Eastern Memorial Hospital

Status

Completed

Conditions

High-risk Endometrial Cancer

Treatments

Drug: adjuvant therapy

Study type

Observational

Funder types

Other

Identifiers

NCT04412902
109053-E

Details and patient eligibility

About

This study will analyze whether there is any difference in recurrence and survival rates among the patients who received different adjuvant therapies.

Full description

The incidence of endometrial cancer is gradually increasing nowaday. The postoperative treatment of high-risk endometrial cancer is also inconsistent. Besides, the recurrence of high-risk endometrial cancer is high.The investigators retrospective study will analyze the factors associated with recurrence of endometrial cancer, especially for different adjuvant therapies.

Enrollment

92 patients

Sex

Female

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients with high risk stage I endometrial cancer and all patients with stage II and stage III endometrial cancer and who underwent therapy in Far Eastern Memorial Hospital from 2009/01/01~2019/09/17.

Exclusion criteria

  • Patients with stage I endometrial cancer do not have high risk factors.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems